{
  "id": "Khorana_Risk_Score_Venous_Thromboembolism_Cancer_Patients.v0",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-08-18",
      "name": "Therese Lindberg",
      "organisation": "Cambio CDS",
      "email": "therese.lindberg@cambio.se"
    },
    "lifecycle_state": "Initial",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To predict risk of VTE for cancer patients depending on type of cancer and other factors.",
        "keywords": [
          "khorana risk score",
          "venous thromboembolism",
          "cancer",
          "pre-chemotherapy",
          "hemoglobin",
          "BMI"
        ],
        "use": "Khorana Risk Score is calculated based on 5 parameters:\nCancer type, Pre-chemotherapy platelet count ≥350x10⁹/L, Hemoglobin level <10 g/dL or using RBC growth factors, Pre-chemotherapy leukocyte count >11x10⁹/L and BMI ≥35 kg/m². Use in general cancer patients (i.e., solid tumors and lymphomas). \n\nScore interpretation:\nRisk Group       Score       2.5-month rate of VTE\nLow                    0             0.3 - 0.8%\nIntermediate      1 - 2         1.8 - 2.0%\nHigh                   ≥3           6.7 - 7.1%",
        "misuse": "Do not use in patients with brain tumors or myelomas.",
        "copyright": "@CambioCDS"
      }
    },
    "other_details": {
      "references": "1. Khorana AA, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008;111:4902-7."
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.lab_test-full_blood_count.v1",
        "template_id": "openEHR-EHR-OBSERVATION.lab_test-full_blood_count.v1",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0078.13]"
          },
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0078.12]"
          }
        }
      },
      "gt0005": {
        "id": "gt0005",
        "model_id": "openEHR-EHR-EVALUATION.khorana_risk_score_venous_thromboembolism_cancer_patients.v0",
        "template_id": "openEHR-EHR-EVALUATION.khorana_risk_score_venous_thromboembolism_cancer_patients.v0",
        "type": "INPUT",
        "elements": {
          "gt0028": {
            "id": "gt0028",
            "path": "/data[at0001]/items[at0013]"
          },
          "gt0030": {
            "id": "gt0030",
            "path": "/data[at0001]/items[at0035]"
          }
        }
      },
      "gt0007": {
        "id": "gt0007",
        "model_id": "openEHR-EHR-OBSERVATION.body_mass_index.v2",
        "template_id": "openEHR-EHR-OBSERVATION.body_mass_index.v2",
        "type": "INPUT",
        "elements": {
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          }
        }
      },
      "gt0009": {
        "id": "gt0009",
        "model_id": "openEHR-EHR-EVALUATION.khorana_risk_score_venous_thromboembolism_cancer_patients.v0",
        "template_id": "openEHR-EHR-EVALUATION.khorana_risk_score_venous_thromboembolism_cancer_patients.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0001]/items[at0029]"
          },
          "gt0012": {
            "id": "gt0012",
            "path": "/data[at0001]/items[at0012]"
          },
          "gt0014": {
            "id": "gt0014",
            "path": "/data[at0001]/items[at0014]"
          },
          "gt0015": {
            "id": "gt0015",
            "path": "/data[at0001]/items[at0015]"
          },
          "gt0016": {
            "id": "gt0016",
            "path": "/data[at0001]/items[at0024]"
          },
          "gt0017": {
            "id": "gt0017",
            "path": "/data[at0001]/items[at0033]"
          },
          "gt0018": {
            "id": "gt0018",
            "path": "/data[at0001]/items[at0025]"
          }
        }
      }
    },
    "default_actions": [
      "$gt0012|Pre-chemotherapy platelet count ≥350x10⁹/L|=0|local::at0016|No +0|",
      "$gt0014|Pre-chemotherapy leukocyte count >11x10⁹/L|=0|local::at0020|No +0|",
      "$gt0015|BMI ≥35 kg/m²|=0|local::at0022|No +0|"
    ],
    "rules": {
      "gt0021": {
        "id": "gt0021",
        "priority": 7,
        "when": [
          "$gt0004|Platelet count|>=350,10*9/l"
        ],
        "then": [
          "$gt0012|Pre-chemotherapy platelet count ≥350x10⁹/L|=1|local::at0017|Yes +1|"
        ]
      },
      "gt0022": {
        "id": "gt0022",
        "priority": 6,
        "when": [
          "$gt0003|Leukocyte count|>11,10*9/l"
        ],
        "then": [
          "$gt0014|Pre-chemotherapy leukocyte count >11x10⁹/L|=1|local::at0021|Yes +1|"
        ]
      },
      "gt0023": {
        "id": "gt0023",
        "priority": 5,
        "when": [
          "$gt0008|Body Mass Index|>=35,kg/m2"
        ],
        "then": [
          "$gt0015|BMI ≥35 kg/m²|=1|local::at0023|Yes +1|"
        ]
      },
      "gt0024": {
        "id": "gt0024",
        "priority": 4,
        "when": [
          "$gt0003|Leukocyte count|!=null",
          "$gt0004|Platelet count|!=null",
          "$gt0008|Body Mass Index|!=null",
          "$gt0028|Hemoglobin level <10 g/dL or using RBC growth factors|!=null"
        ],
        "then": [
          "$gt0016|Khorana Risk Score|.magnitude=$gt0012.value+$gt0014.value+$gt0015.value+$gt0028.value+$gt0030.value",
          "$gt0017|Comment|='Note; Median follow-up time was 2.5 months.'"
        ]
      },
      "gt0025": {
        "id": "gt0025",
        "priority": 3,
        "when": [
          "$gt0016|Khorana Risk Score|>=3"
        ],
        "then": [
          "$gt0018|Risk Group|=local::at0028|High|",
          "$gt0011|2.5-month rate of VTE|=local::at0032|6.7 - 7.1%|"
        ]
      },
      "gt0026": {
        "id": "gt0026",
        "priority": 2,
        "when": [
          "$gt0016|Khorana Risk Score|<3",
          "$gt0016|Khorana Risk Score|>0"
        ],
        "then": [
          "$gt0018|Risk Group|=local::at0027|Intermediate|",
          "$gt0011|2.5-month rate of VTE|=local::at0031|1.8 - 2.0%|"
        ]
      },
      "gt0027": {
        "id": "gt0027",
        "priority": 1,
        "when": [
          "$gt0016|Khorana Risk Score|==0"
        ],
        "then": [
          "$gt0018|Risk Group|=local::at0026|Low|",
          "$gt0011|2.5-month rate of VTE|=local::at0030|0.3 - 0.8%|"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Khorana Risk Score for Venous Thromboembolism in Cancer Patients",
            "description": "Khorana Risk Score for Venous Thromboembolism in Cancer Patients predicts risk of VTE for cancer patients depending on type of cancer and other factors."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Leukocyte count",
            "description": "The number of white cells per litre"
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Platelet count",
            "description": "The number of platelets per litre"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Body Mass Index",
            "description": "Index describing ratio of weight to height."
          },
          "gt0011": {
            "id": "gt0011",
            "text": "2.5-month rate of VTE",
            "description": "*"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "Pre-chemotherapy platelet count ≥350x10⁹/L",
            "description": "*"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Pre-chemotherapy leukocyte count >11x10⁹/L",
            "description": "*"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "BMI ≥35 kg/m²",
            "description": "*"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "Khorana Risk Score",
            "description": "*"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "Comment",
            "description": "*"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "Risk Group",
            "description": "*"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "Pre-chemotherapy platelet count ≥350x10⁹/L"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "Pre-chemotherapy leukocyte count >11x10⁹/L"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "BMI ≥35 kg/m²"
          },
          "gt0024": {
            "id": "gt0024",
            "text": "Calculate Khorana Risk Score "
          },
          "gt0025": {
            "id": "gt0025",
            "text": "Risk Group: High"
          },
          "gt0026": {
            "id": "gt0026",
            "text": "Risk Group: Intermediate"
          },
          "gt0027": {
            "id": "gt0027",
            "text": "Risk Group: Low"
          },
          "gt0028": {
            "id": "gt0028",
            "text": "Hemoglobin level <10 g/dL or using RBC growth factors",
            "description": "*"
          },
          "gt0030": {
            "id": "gt0030",
            "text": "Cancer Type",
            "description": "*"
          }
        }
      }
    }
  }
}